Cochlear Limited

World Rank (Aug-2026)

3064

Market Cap (Aug-2026)

6.353 Billion USD

World Rank (Jan-05-2024)

1,330

Market Cap (Jan-05-2024)

13.083 Billion USD

World Rank (Jul-30-2023)

1,620

Market Cap (Jul-30-2023)

10.445 Billion USD

World Rank (Jan-07-2022)

1,912

Market Cap (Jan-07-2022)

9.851 Billion USD

World Rank (Jan-01-2021)

1,744

Market Cap (Jan-01-2021)

9.553 Billion USD

Company Rank in Country in 2023

Rank in Australia in July-2023 is 28

Headquarters Country

Australia

Top Healthcare Companies in Australia

Employee Count

4,800

Employee Count as of Date

As on 2023

Headquarters City/State

Sydney

World Region

Oceania

World Subregion

Australia and New Zealand

Annual Revenue in USD

1,561 Million USD

Annual Operating Income in USD

139 Million USD

Annual Net Income in USD

98 Million USD

Annual Results for Period Ending

For year ending June-2026

Total Assets in USD

1,731 Million USD

Total Liabilities in USD

574 Million USD

Total Equity in USD

1,158 Million USD

Balance Sheet for Period Ending

As of June-2026

Business Sector

Healthcare

Medical Equipment / Instruments

HealthCare Products

Company Website

COCHLEAR LIMITED - Medical Equipment Manufacture Company

Wikipedia

Yahoo

Yahoo @ ASX

Company Profile

Cochlear Limited is Medical Equipment manufacture and research company based in Australia. Cochlear Limited is the leading global expert in implantable hearing solutions. Cochlear hearing implants are the latest and most innovative hearing implant devices available. Headquarters is in Australia.

Facts About Company

As on Jun-2022, Cochlear Limited has Annual Revenue is 1,648 million AUD and net income was 289 million AUD.

As on Jun-2021, Cochlear Limited has Annual Revenue is 1,497 million AUD and net income was 326 million AUD.

As on 2023, Cochlear Limited had 4,800 employees.

Annual Results Summary

COCHLEAR LIMITED - Revenue and Net Profit - Year Wise - in Million AUD:

Fiscal Year	Period Ending	Total Annual Revenue (AUD mm)	Gross Profit (AUD mm)	Operating Profit / EBIT (AUD mm)	Net Income (AUD mm)
2025	Jun-30-2025	2,343.1	1,727.9	517.8	388.9
2024	Jun-30-2024	2,235.6	1,673.5	475.0	356.8
2023	Jun-30-2023	1,936.1	1,448.1	389.5	300.6
2022	Jun-30-2022	1,648.3	1,237.3	400.0	289.1
2021	Jun-30-2021	1,497.6	1,087.4	370.2	323.8
2020	Jun-30-2020	1,320.6	976.2	(262.2)	(238.3)
2019	Jun-30-2019	1,426.7	1,075.6	370.1	276.7
2018	Jun-30-2018	1,363.7	1,002.5	348.4	245.8
2017	Jun-30-2017	1,253.8	895.5	315.6	223.6
2016	Jun-30-2016	1,130.6	797.0	262.6	188.9

Balance Sheet Summary

COCHLEAR LIMITED - Balance Sheet Summary - in Million AUD:

Fiscal Year	Total Assets (AUD M)	Total Liabilities (AUD M)	Total Equity (AUD M)
2025	2,825.000	874.700	1,950.300
2024	2,745.100	904.600	1,840.500
2023	2,568.700	819.900	1,748.800
2022	2,465.100	779.400	1,685.700
2021	2,438.200	736.500	1,701.700
2020	2,575.700	1,174.200	1,401.500
2019	1,379.200	653.300	725.900
2018	1,156.900	546.100	610.800
2017	1,136.359	592.712	543.647
2016	957.363	508.806	448.557